Integrating Chinese medicine into mainstream cancer therapies: a promising future

• DOI: 10.3389/fonc.2024.1412370
• Publication Date: 2024-06-18T05:38:13Z
• Authors: Baoyi Ni; Kaiyuan Xue; Jia Wang; Jilai Zhou; Lankang Wang; Xinmiao Wang; Ting Liu; Naijing Ye; Jiakang Jiang
• Keywords: 0301 basic medicine; 03 medical and health sciences; drug resistance; Oncology; Chinese patent medicine; Chinese herb monomer; adverse effects; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; adjuvant therapy; malignant tumors; RC254-282

Malignant tumors are complex systemic chronic diseases and one of the major causes human mortality. Targeted therapy, chemotherapy, immunotherapy, radiotherapy examples mainstream allopathic medicine treatments that effective for intermediate advanced malignant tumors. The ongoing use conventional has resulted in adverse responses drug resistance, which have hampered its efficacy. As an important component complementary alternative medicine, Chinese been found to antitumor effects played role enhancing therapeutic sensitivity reducing incidence events improving immune-related functions. combined application adjuvant begun gain acceptance is gradually used field therapy. Traditional natural medicines their active ingredients, as well patent medicines, proven excellent efficacy good safety treatment various This paper focuses on mechanism action research progress combining above drugs with increase sensitivity, alleviate reduce reactions, improve body’s immune function. To encourage clinical development herb therapy provide ideas information creating safer more anticancer medication combinations, significant functions therapies cancer described detail.